During the past decade, OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center conducted 92 clinical trials. In the 10-year time frame, 92 clinical trials started and 103 clinical trials were completed, i.e. on average, 112% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 65 clinical trials were completed. i.e. 361.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center" #1 sponsor was "National Cancer Institute (NCI)" with 103 trials, followed by "SWOG Cancer Research Network" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 21 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored and "GOG Foundation" with 9 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center" #1 collaborator was "National Cancer Institute (NCI)" with 75 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center" are "Recurrent Breast Carcinoma" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Breast Cancer AJCC v6 and v7" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Recurrent Ovarian Carcinoma" (7 trials). Many other conditions were trialed in "OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center" in a lesser frequency.

Most popular intervention types in "OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center" are "Drug" (145 trials), "Other" (127 trials), "Biological" (75 trials), "Procedure" (35 trials) and "Radiation" (34 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (88 trials), "Quality-of-Life Assessment" (40 trials), "Cisplatin" (31 trials), "Carboplatin" (22 trials) and "Paclitaxel" (21 trials). Other intervention names were less common.

The vast majority of trials in "OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center" are 140 trials for "All" genders, 35 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center". undefined are not yet recruiting, 24 are recruiting, 94 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center, 4 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center, 14 "Phase 1" clinical trials were conducted, 89 "Phase 2" clinical trials and 92 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".